{
  "DOI": "10.1007/s10689-014-9747-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-014-9747-y",
  "alternative-id": [
    "9747"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Ahlborn",
      "given": "Lise B.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Steffensen",
      "given": "Ane Y.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jønson",
      "given": "Lars",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Djursby",
      "given": "Malene",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nielsen",
      "given": "Finn C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gerdes",
      "given": "Anne-Marie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hansen",
      "given": "Thomas V. O.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2014,
        8,
        25
      ]
    ],
    "date-time": "2014-08-25T08:47:34Z",
    "timestamp": 1408956454000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:14Z",
    "timestamp": 1559252774000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        13
      ]
    ],
    "date-time": "2024-03-13T09:22:30Z",
    "timestamp": 1710321750006
  },
  "is-referenced-by-count": 11,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2014,
        8,
        26
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2015,
          3
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2014,
            8,
            26
          ]
        ],
        "date-time": "2014-08-26T00:00:00Z",
        "timestamp": 1409011200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9747-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-014-9747-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9747-y",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "129-133",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2014,
        8,
        26
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2014,
        8,
        26
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1126/science.1088759",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "issue": "5645",
      "journal-title": "Science",
      "key": "9747_CR1",
      "unstructured": "King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646. doi: 10.1126/science.1088759",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s13402-011-0010-3",
      "doi-asserted-by": "crossref",
      "key": "9747_CR2",
      "unstructured": "van der Groep P, van der Wall E, van Diest PJ (2011) Pathology of hereditary breast cancer. Cell Oncol (Dordr) 34(2):71–88. doi: 10.1007/s13402-011-0010-3"
    },
    {
      "DOI": "10.1093/nar/30.10.2172",
      "author": "BC Godthelp",
      "doi-asserted-by": "crossref",
      "first-page": "2172",
      "issue": "10",
      "journal-title": "Nucleic Acids Res",
      "key": "9747_CR3",
      "unstructured": "Godthelp BC, Wiegant WW, van Duijn-Goedhart A et al (2002) Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res 30(10):2172–2182",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1074/jbc.M609066200",
      "author": "Y Liu",
      "doi-asserted-by": "crossref",
      "first-page": "1973",
      "issue": "3",
      "journal-title": "J Biol Chem",
      "key": "9747_CR4",
      "unstructured": "Liu Y, Tarsounas M, O’Regan P, West SC (2007) Role of RAD51C and XRCC3 in genetic recombination and DNA repair. J Biol Chem 282(3):1973–1979",
      "volume": "282",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ng.570",
      "doi-asserted-by": "crossref",
      "key": "9747_CR5",
      "unstructured": "Vaz F, Hanenberg H, Schuster B et al (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 42(5):406–409"
    },
    {
      "DOI": "10.1007/s10549-012-2317-9",
      "doi-asserted-by": "crossref",
      "key": "9747_CR6",
      "unstructured": "Kushnir A, Laitman Y, Shimon SP, Berger R, Friedman E (2012) Germline mutations in RAD51C in Jewish high cancer risk families. Breast Cancer Res Treat 136(3): 869–874. doi: 10.1007/s10549-012-2317-9"
    },
    {
      "DOI": "10.1038/ng.569",
      "doi-asserted-by": "crossref",
      "key": "9747_CR7",
      "unstructured": "Meindl A, Hellebrand H, Wiek C, et al (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42(5):410–414"
    },
    {
      "DOI": "10.1093/hmg/dds115",
      "doi-asserted-by": "crossref",
      "key": "9747_CR8",
      "unstructured": "Osorio A, Endt D, Fernandez F et al (2012) Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families. Hum Mol Genet 21(13):2889–2898"
    },
    {
      "DOI": "10.1172/JCI58321",
      "doi-asserted-by": "crossref",
      "key": "9747_CR9",
      "unstructured": "Kee Y, D’Andrea AD (2012) Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest 122(11):3799–3806"
    },
    {
      "DOI": "10.1002/humu.20896",
      "author": "SV Tavtigian",
      "doi-asserted-by": "crossref",
      "first-page": "1342",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "9747_CR10",
      "unstructured": "Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A (2008) Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. Hum Mutat 29(11):1342–1354. doi: 10.1002/humu.20896",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ejhg.2011.100",
      "doi-asserted-by": "crossref",
      "key": "9747_CR11",
      "unstructured": "Thery JC, Krieger S, Gaildrat P et al (2011) Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet 19(10):1052–1058"
    },
    {
      "DOI": "10.1038/ejhg.2014.40",
      "doi-asserted-by": "crossref",
      "key": "9747_CR12",
      "unstructured": "Steffensen AY, Dandanell M, Jonson L et al (2014) Functional characterization of BRCA1 gene variants by mini-gene splicing assay. Eur J Hum Genet. doi: 10.1038/ejhg.2014.40"
    },
    {
      "DOI": "10.1111/j.1399-0004.2005.00484.x",
      "author": "DG Cruger",
      "doi-asserted-by": "crossref",
      "first-page": "228",
      "issue": "3",
      "journal-title": "Clin Genet",
      "key": "9747_CR13",
      "unstructured": "Cruger DG, Kruse TA, Gerdes AM (2005) ‘Indirect’ BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative. Clin Genet 68(3):228–233",
      "volume": "68",
      "year": "2005"
    },
    {
      "DOI": "10.1002/humu.20811",
      "author": "MP Vreeswijk",
      "doi-asserted-by": "crossref",
      "first-page": "107",
      "issue": "1",
      "journal-title": "Hum Mutat",
      "key": "9747_CR14",
      "unstructured": "Vreeswijk MP, Kraan JN, van der Klift HM et al (2009) Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs. Hum Mutat 30(1):107–114. doi: 10.1002/humu.20811",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmg.2004.027243",
      "author": "B Leegte",
      "doi-asserted-by": "crossref",
      "first-page": "e20",
      "issue": "3",
      "journal-title": "J Med Genet",
      "key": "9747_CR15",
      "unstructured": "Leegte B, van der Hout AH, Deffenbaugh AM et al (2005) Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet 42(3):e20",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1136/jmg.39.8.e44",
      "author": "T Caldes",
      "doi-asserted-by": "crossref",
      "first-page": "e44",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "9747_CR16",
      "unstructured": "Caldes T, de la Hoya M, Tosar A et al (2002) A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes. J Med Genet 39(8):e44",
      "volume": "39",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2004.04.179",
      "author": "DH Choi",
      "doi-asserted-by": "crossref",
      "first-page": "1638",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "9747_CR17",
      "unstructured": "Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22(9):1638–1645. doi: 10.1200/JCO.2004.04.179",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10689-007-9154-8",
      "author": "M Smith",
      "doi-asserted-by": "crossref",
      "first-page": "119",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "9747_CR18",
      "unstructured": "Smith M, Fawcett S, Sigalas E et al (2008) Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes. Fam Cancer 7(2):119–124. doi: 10.1007/s10689-007-9154-8",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10689-010-9345-6",
      "doi-asserted-by": "crossref",
      "key": "9747_CR19",
      "unstructured": "Steffensen AY, Jonson L, Ejlertsen B, Gerdes AM, Nielsen FC, Hansen TV (2010) Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations. Fam Cancer 9(3): 283–287. doi: 10.1007/s10689-010-9345-6"
    },
    {
      "DOI": "10.1007/s11912-013-0371-z",
      "doi-asserted-by": "crossref",
      "key": "9747_CR20",
      "unstructured": "Rainville IR, Rana HQ (2014) Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Curr Oncol Rep 16(3):371. doi: 10.1007/s11912-013-0371-z"
    },
    {
      "DOI": "10.1038/onc.2013.421",
      "doi-asserted-by": "crossref",
      "key": "9747_CR21",
      "unstructured": "Park JY, Singh TR, Nassar N et al (2013) Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene. doi: 10.1038/onc.2013.421"
    },
    {
      "key": "9747_CR22",
      "unstructured": "Alamut version 2.2 (Interactive Biosoftware, Rouen, France)"
    },
    {
      "DOI": "10.1074/jbc.M308621200",
      "author": "CA French",
      "doi-asserted-by": "crossref",
      "first-page": "45445",
      "issue": "46",
      "journal-title": "J Biol Chem",
      "key": "9747_CR23",
      "unstructured": "French CA, Tambini CE, Thacker J (2003) Identification of functional domains in the RAD51L2 (RAD51C) protein and its requirement for gene conversion. J Biol Chem 278(46):45445–45450. doi: 10.1074/jbc.M308621200",
      "volume": "278",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.297.5588.1837",
      "author": "H Yang",
      "doi-asserted-by": "crossref",
      "first-page": "1837",
      "issue": "5588",
      "journal-title": "Science",
      "key": "9747_CR24",
      "unstructured": "Yang H, Jeffrey PD, Miller J et al (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297(5588):1837–1848. doi: 10.1126/science.297.5588.1837",
      "volume": "297",
      "year": "2002"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-12-2081",
      "doi-asserted-by": "crossref",
      "key": "9747_CR25",
      "unstructured": "Guidugli L, Pankratz VS, Singh N et al (2013) A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res 73(1):265–275"
    },
    {
      "DOI": "10.1002/1098-1004(200008)16:2\u003c123::AID-HUMU4\u003e3.0.CO;2-Y",
      "author": "C Szabo",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "issue": "2",
      "journal-title": "Hum Mutat",
      "key": "9747_CR26",
      "unstructured": "Szabo C, Masiello A, Ryan JF, Brody LC (2000) The breast cancer information core: database design, structure, and scope. Hum Mutat 16(2):123–131. doi: 10.1002/1098-1004(200008)16:2\u003c123:AID-HUMU4\u003e3.0.CO;2-Y",
      "volume": "16",
      "year": "2000"
    }
  ],
  "reference-count": 26,
  "references-count": 26,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-014-9747-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}